Asia Pacific Bovine Diagnostics Market Forecast to 2030
Asia Pacific Bovine Diagnostics Market Forecast to 2030 – Regional Analysis – by Product [Immunoassay Kits, PCR Reagents & Kits, Hemagglutination Inhibition (HI) Assay, and Other Products], Disease Type [Bovine Viral Diarrhea (BVD), Bovine Tuberculosis (TB), Bovine Mastitis, Foot and Mouth Disease (FMD), and Other Disease Type], and End User (Veterinary Hospitals, Veterinary Clinics, and Other End-Users)
$2,485 – $3,885
- Description
- Toplines
- Reasons for Buying
- Table of Contents
- List of Tables
- LIst of Figures
- List of Companies
- Reviews (0)
Description
High Prevalence of Bovine Tuberculosis Fuels Asia Pacific Bovine Diagnostics Market
Bovine tuberculosis (bTB) is a chronic infectious disease that primarily affects cattle and is later transmitted to other animals and humans. The World Organization for Animal Health (WOAH) has listed bTB as one of the diseases that must be detected and reported as earliest as possible. As per the data shared by Thermo Fisher Scientific in May 2023, bTB affects more than 50 million cattle worldwide, incurring annual economic losses of ~US$ 3 billion.
The prevalence of bTB differs in different geographic areas. However, its prevalence reaches beyond bTB 50% in some parts of Asia. Despite the ongoing technological and infrastructural developments, many countries fail to effectively diagnose bTB due to the complexity of the disease and the lack of universal strategies for its diagnosis. This scenario provides opportunities for bovine diagnostics market players to enhance awareness in Asia and launch new products that suit the socioeconomic conditions in these countries.
Asia Pacific Bovine Diagnostics Market Overview
The Asia Pacific bovine diagnostics market in Asia Pacific is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. According to an article published in BMC Journals in 2023, bTB is a major endemic in China that results in major losses in dairy cattle production. In its Medium and Long-Term National Plan for Prevention and Control of Animal Diseases (2012–2020), the Ministry of Agriculture and Rural Affairs in China has classified the bTB of dairy cattle as one of the 16 infectious diseases that should be controlled and eliminated, as the disease also affects human welfare in addition to the livestock industry. A milk-based test is performed for diseases such as bovine brucellosis, Mycoplasma bovis (M. bovis) disease, paratuberculosis, and bovine leukosis. The collection and testing of milk samples do not have much impact on dairy cows, which also results in greater cooperation from dairy workers. The National Dairy Herd Improvement (DHI) Program of China also emphasizes on the collection of milk samples from lactating cows monthly, followed by testing them to assess breeding suitability and milk quality. It also recommends evaluating the milk samples to detect mastitis in the early stages using a CombiFoss FT + milk composition and a somatic cell analyzer. China implements its current bTB control strategy through test-and-slaughter policies, which are based on surveillance programs at the national and local levels, as well as on farms. Mycobacterium bovis culture is the “gold standard” for diagnosing bTB. However, the identification of M. bovis by culturing it is insensitive, cumbersome, and time-consuming, and it requires high-level biosafety laboratory facilities because of the persistent infection, slow growth, and potentially dangerous characteristics of the pathogen. Currently, the tuberculin skin test is the recommended and conventional test performed on animals at farms in China for detecting bTB, while the blood interferon-gamma in vitro release test is an alternative laboratory diagnostic test available. Thus, increasing bTB disease and support by government for diagnosis boosts the growth of bovine diagnostics market growth in China.
Asia Pacific Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Million)
Asia Pacific Bovine Diagnostics Market Segmentation
The Asia Pacific bovine diagnostics market is segmented into product, disease type, end user, and country.
Based on product, the Asia Pacific bovine diagnostics market is segmented into immunoassay kits, PCR reagents & kits, hemagglutination inhibition (HI) assay, and other products. The immunoassay kits segment held the largest share of the Asia Pacific bovine diagnostics market in 2022.
Based on disease type, the Asia Pacific bovine diagnostics market is segmented into bovine viral diarrhea (BVD), bovine tuberculosis (TB), bovine mastitis, foot and mouth disease (FMD), and other disease types. The bovine mastitis segment held the largest share of the Asia Pacific bovine diagnostics market in 2022.
Based on end user, the Asia Pacific bovine diagnostics market is segmented into veterinary hospitals, veterinary clinics, and other end-users. The veterinary hospitals segment held the largest share of the Asia Pacific bovine diagnostics market in 2022.
Based on country, the Asia Pacific bovine diagnostics market is segmented int o China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific bovine diagnostics market in 2022.
bioMerieux SA, Bionote Inc, Idexx Laboratories Inc, Innovative Diagnostics SAS, Neogen Corp, Ring Biotechnology Co Ltd, Shenzhen Bioeasy Biotechnology Co Ltd, and Thermo Fisher Scientific Inc are some of the leading companies operating in the Asia Pacific bovine diagnostics market.
Summary Info
| Industry: | |
|---|---|
| Pricing options: | |
| Geographical coverage: | |
| Year of Publication: |
According to The Research Team’ research, the Asia Pacific bovine diagnostics market was valued at US$ 250.42 million in 2022 and is expected to reach US$ 482.94 million by 2030, registering a CAGR of 8.6% from 2022 to 2030. High prevalence and economic impact of bovine mastitis and increasing number of product launches are among the critical factors attributed to the Asia Pacific bovine diagnostics market expansion.
Continuous research and development efforts allow veterinary diagnostics companies to launch various innovative diagnostics products that provide rapid results. In addition, growing awareness among end users through the government’s educative and knowledge-sharing programs has encouraged these companies to introduce advanced diagnostics products. A few of the recent product launches in the bovine diagnostics market have been mentioned below.
In June 2023, Zoetis, Inc launched Vetscan Mastigram+, an on-farm mastitis diagnostic solution that provides results 8 hours before the next milking. The Vetscan Mastigram+ uses a flow dipstick test to detect Gram-positive mastitis in cattle. The product would detect the presence of Gram-positive pathogens in cow milk with 99% sensitivity and 100% specificity, along with differentiating between for Gram-positive and Gram-negative bacteria.
In June 2023, Neogen Corporation launched Igenity BeefXDairy, a DNA test for beef-on-dairy cattle. The test would provide insights into the traits such as carcass quality, average daily gain, and the Igenity Terminal Index to the producers. In addition, it would allow buyers to receive breed composition data to help them with optimal cattle health management and maximize the cattle product yield.
On the contrary, lack of skilled professionals in veterinary research hampers the Asia Pacific bovine diagnostics market.
Based on product, the Asia Pacific bovine diagnostics market is segmented into immunoassay kits, PCR reagents & kits, hemagglutination inhibition (HI) assay, and other products. The immunoassay kits segment held 46.5% share of Asia Pacific bovine diagnostics market in 2022, amassing US$ 116.46 million. It is projected to garner US$ 237.89 million by 2030 to expand at 9.3% CAGR during 2022–2030.
Based on disease type, the Asia Pacific bovine diagnostics market is segmented into bovine viral diarrhea (BVD), bovine tuberculosis (TB), bovine mastitis, foot and mouth disease (FMD), and other disease types. The bovine mastitis segment held 35.0% share of Asia Pacific bovine diagnostics market in 2022, amassing US$ 87.66 million. It is projected to garner US$ 178.06 million by 2030 to expand at 9.3% CAGR during 2022–2030.
Based on end user, the Asia Pacific bovine diagnostics market is segmented into veterinary hospitals, veterinary clinics, and other end-users. The veterinary hospitals segment held 52.6% share of Asia Pacific bovine diagnostics market in 2022, amassing US$ 131.83 million. It is projected to garner US$ 265.91 million by 2030 to expand at 9.2% CAGR during 2022–2030.
Based on country, the Asia Pacific bovine diagnostics market has been categorized into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. Our regional analysis states that China captured 24.3% share of Asia Pacific bovine diagnostics market in 2022. It was assessed at US$ 60.94 million in 2022 and is likely to hit US$ 131.30 million by 2030, exhibiting a CAGR of 10.1% during 2022–2030.
Key players operating in the Asia Pacific bovine diagnostics market are bioMerieux SA, Bionote Inc, Idexx Laboratories Inc, Innovative Diagnostics SAS, Neogen Corp, Ring Biotechnology Co Ltd, Shenzhen Bioeasy Biotechnology Co Ltd, and Thermo Fisher Scientific Inc, among others.
o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific Bovine Diagnostics Market.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific Bovine Diagnostics Market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
TABLE OF CONTENTS
1. Introduction
1.1 The Research Team Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Bovine Diagnostics Market – Key Industry Dynamics
4.1 Key Market Drivers:
4.1.1 High Prevalence and Economic Impact of Bovine Mastitis
4.1.2 Increasing Number of Product Launches
4.2 Key Market Restraints:
4.2.1 Lack of Skilled Professionals in Veterinary Research
4.3 Key Market Opportunities:
4.3.1 High Prevalence of Bovine Tuberculosis
4.4 Future Trends
4.4.1 Integration of Data Analytics and Artificial Intelligence (AI)
4.5 Impact Analysis:
5. Bovine Diagnostics Market – Asia Pacific Market Analysis
5.1 Asia Pacific Bovine Diagnostics Market Revenue (US$ Mn), 2022 – 2030
6. Asia Pacific Bovine Diagnostics Market – Revenue and Forecast to 2030 – by Product
6.1 Overview
6.2 Asia Pacific Bovine Diagnostics Market Revenue Share, by Product 2022 & 2030 (%)
6.3 Immunoassay Kits
6.3.1 Overview
6.3.2 Immunoassay Kits: Asia Pacific Bovine Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
6.4 PCR Kits
6.4.1 Overview
6.4.2 PCR Kits: Asia Pacific Bovine Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
6.5 Hemagglutination Inhibition (HI) Assay
6.5.1 Overview
6.5.2 Hemagglutination Inhibition (HI) Assay: Asia Pacific Bovine Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
6.6 Other Products
6.6.1 Overview
6.6.2 Other Products: Asia Pacific Bovine Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7. Asia Pacific Bovine Diagnostics Market – Revenue and Forecast to 2030 – by Disease Type
7.1 Overview
7.2 Asia Pacific Bovine Diagnostics Market Revenue Share, by Disease Type 2022 & 2030 (%)
7.3 Bovine Viral Diarrhea (BVD)
7.3.1 Overview
7.3.2 Bovine Viral Diarrhea (BVD): Asia Pacific Bovine Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Bovine Tuberculosis (TB)
7.4.1 Overview
7.4.2 Bovine Tuberculosis (TB): Asia Pacific Bovine Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Bovine Mastitis
7.5.1 Overview
7.5.2 Bovine Mastitis: Asia Pacific Bovine Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.6 Foot and Mouth Disease (FMD)
7.6.1 Overview
7.6.2 Foot and Mouth Disease (FMD): Asia Pacific Bovine Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.7 Other Disease Types
7.7.1 Overview
7.7.2 Other Disease Types: Asia Pacific Bovine Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8. Asia Pacific Bovine Diagnostics Market – Revenue and Forecast to 2030 – by End User
8.1 Overview
8.2 Asia Pacific Bovine Diagnostics Market Revenue Share, by end user 2022 & 2030 (%)
8.3 Veterinary Hospitals
8.3.1 Overview
8.3.2 Veterinary Hospitals: Asia Pacific Bovine Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Veterinary Clinics
8.4.1 Overview
8.4.2 Veterinary Clinics: Asia Pacific Bovine Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Other End-Users
8.5.1 Overview
8.5.2 Other End-Users: Asia Pacific Bovine Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9. Asia Pacific Bovine Diagnostics Market – Country Analysis
9.1.1.1 Asia Pacific Bovine Diagnostics Market, by Country
9.1.1.2 China
9.1.1.2.1 Overview
9.1.1.2.2 China: Asia Pacific Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
9.1.1.2.3 China: Asia Pacific Bovine Diagnostics Market, by Product
9.1.1.2.4 China: Asia Pacific Bovine Diagnostics Market, by Disease Type
9.1.1.2.5 China: Asia Pacific Bovine Diagnostics Market, by End User
9.1.1.3 Japan
9.1.1.3.1 Overview
9.1.1.3.2 Japan: Asia Pacific Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
9.1.1.3.3 Japan: Asia Pacific Bovine Diagnostics Market, by Product
9.1.1.3.4 Japan: Asia Pacific Bovine Diagnostics Market, by Disease Type
9.1.1.3.5 Japan: Asia Pacific Bovine Diagnostics Market, by End User
9.1.1.4 India
9.1.1.4.1 Overview
9.1.1.4.2 India: Asia Pacific Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
9.1.1.4.3 India: Asia Pacific Bovine Diagnostics Market, by Product
9.1.1.4.4 India: Asia Pacific Bovine Diagnostics Market, by Disease Type
9.1.1.4.5 India: Asia Pacific Bovine Diagnostics Market, by End User
9.1.1.5 South Korea
9.1.1.5.1 Overview
9.1.1.5.2 South Korea: Asia Pacific Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
9.1.1.5.3 South Korea: Asia Pacific Bovine Diagnostics Market, by Product
9.1.1.5.4 South Korea: Asia Pacific Bovine Diagnostics Market, by Disease Type
9.1.1.5.5 South Korea: Asia Pacific Bovine Diagnostics Market, by End User
9.1.1.6 Australia
9.1.1.6.1 Overview
9.1.1.6.2 Australia: Asia Pacific Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
9.1.1.6.3 Australia: Asia Pacific Bovine Diagnostics Market, by Product
9.1.1.6.4 Australia: Asia Pacific Bovine Diagnostics Market, by Disease Type
9.1.1.6.5 Australia: Asia Pacific Bovine Diagnostics Market, by End User
9.1.1.7 Rest of Asia Pacific
9.1.1.7.1 Overview
9.1.1.7.2 Rest of Asia Pacific: Asia Pacific Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
9.1.1.7.3 Rest of Asia Pacific: Asia Pacific Bovine Diagnostics Market, by Product
9.1.1.7.4 Rest of Asia Pacific: Asia Pacific Bovine Diagnostics Market, by Disease Type
9.1.1.7.5 Rest of Asia Pacific: Asia Pacific Bovine Diagnostics Market, by End User
10. Bovine Diagnostics Market – Industry Landscape
10.1 Overview
10.2 Growth Strategies
10.2.1 Overview
11. Company Profiles
11.1 Idexx Laboratories Inc
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Thermo Fisher Scientific Inc
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Innovative Diagnostics SAS
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Neogen Corp
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 bioMerieux SA
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Ring Biotechnology Co Ltd
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Bionote Inc
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 Shenzhen Bioeasy Biotechnology Co Ltd
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments
12. Appendix
12.1 About Us
12.2 Glossary of Terms
LIST OF TABLES
Table 1. Asia Pacific Bovine Diagnostics Market Segmentation
Table 2. China: Asia Pacific Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) – Product
Table 3. China: Asia Pacific Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) – Disease Type
Table 4. China: Asia Pacific Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) – End User
Table 5. Japan: Asia Pacific Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) – Product
Table 6. Japan: Asia Pacific Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) – Disease Type
Table 7. Japan: Asia Pacific Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) – End User
Table 8. India: Asia Pacific Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) – Product
Table 9. India: Asia Pacific Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) – Disease Type
Table 10. India: Asia Pacific Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) – End User
Table 11. South Korea: Asia Pacific Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) – Product
Table 12. South Korea: Asia Pacific Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) – Disease Type
Table 13. South Korea: Asia Pacific Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) – End User
Table 14. Australia: Asia Pacific Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) – Product
Table 15. Australia: Asia Pacific Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) – Disease Type
Table 16. Australia: Asia Pacific Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) – End User
Table 17. Rest of Asia Pacific: Asia Pacific Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) – Product
Table 18. Rest of Asia Pacific: Asia Pacific Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) – Disease Type
Table 19. Rest of Asia Pacific: Asia Pacific Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) – End User
Table 20. Recent Growth Strategies in Asia Pacific Bovine Diagnostics Market
Table 21. Glossary of Terms, Asia Pacific Bovine Diagnostics Market
LIST OF FIGURES
Figure 1. Asia Pacific Bovine Diagnostics Market Segmentation, By Country
Figure 2. Key Insights
Figure 3. Market Attractiveness
Figure 4. Asia Pacific Bovine Diagnostics Market – Key Industry Dynamics
Figure 5. Impact Analysis of Drivers and Restraints
Figure 6. Asia Pacific Bovine Diagnostics Market Revenue (US$ Mn), 2022 – 2030
Figure 7. Asia Pacific Bovine Diagnostics Market Revenue Share, by Product 2022 & 2030 (%)
Figure 8. Immunoassay Kits: Asia Pacific Bovine Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. PCR Kits: Asia Pacific Bovine Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Hemagglutination Inhibition (HI) Assay: Asia Pacific Bovine Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Other Products: Asia Pacific Bovine Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Asia Pacific Bovine Diagnostics Market Revenue Share, by Disease Type 2022 & 2030 (%)
Figure 13. Bovine Viral Diarrhea (BVD): Asia Pacific Bovine Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Bovine Tuberculosis (TB): Asia Pacific Bovine Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Bovine Mastitis: Asia Pacific Bovine Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Foot and Mouth Disease (FMD): Asia Pacific Bovine Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Other Disease Types: Asia Pacific Bovine Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Asia Pacific Bovine Diagnostics Market Revenue Share, by end user 2022 & 2030 (%)
Figure 19. Veterinary Hospitals: Asia Pacific Bovine Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. Veterinary Clinics: Asia Pacific Bovine Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. Other End-Users: Asia Pacific Bovine Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. Asia Pacific Bovine Diagnostics Market, By Country, 2022 ($Mn)
Figure 23. Asia Pacific Bovine Diagnostics Market, By Key Countries, 2022 And 2030 (%)
Figure 24. China: Asia Pacific Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
Figure 25. Japan: Asia Pacific Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
Figure 26. India: Asia Pacific Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
Figure 27. South Korea: Asia Pacific Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
Figure 28. Australia: Asia Pacific Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
Figure 29. Rest of Asia Pacific: Asia Pacific Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
The List of Companies – Asia Pacific Bovine Diagnostics Market
o bioMerieux SA
o Bionote Inc
o Idexx Laboratories Inc
o Innovative Diagnostics SAS
o Neogen Corp
o Ring Biotechnology Co Ltd
o Shenzhen Bioeasy Biotechnology Co Ltd
o Thermo Fisher Scientific Inc
You must be logged in to post a review.
Reviews
There are no reviews yet.